Observe the Effect of Wheatgrass and Tulsi Formulation or Individuals Taken With Other Allopathic Drugs
Observation of Wheatgrass and Tulsi Formulation or Its Effect With Allopathic Drugs
1 other identifier
observational
100
1 country
1
Brief Summary
Antioxidant qualities have been attributed to wheatgrass and tulsi formulation. Free radicals are unstable molecules created by the body during metabolism and exposure to environmental pollutants. Antioxidants are chemicals that can help stop or reduce cell damage caused by these unstable molecules. Oxidative stress, which is brought on by free radicals, has been connected to a number of health issues, including chronic inflammation, cardiovascular disease, cancer, and ageing. Wheatgrass is a rich source of vitamins, minerals, amino acids, and chlorophyll, which have been shown to have antioxidant and anti-inflammatory effects. Tulsi, also known as holy basil, is an herb that has been used in Ayurvedic medicine for centuries and has been found to have antioxidant, anti-inflammatory, and immunomodulatory properties. Several studies have investigated the antioxidant properties of wheatgrass and tulsi formulation. For instance, a study published in the Journal of Food Science and Technology in 2015 found that wheatgrass extract had significant antioxidant activity, as measured by its ability to scavenge free radicals and reduce lipid peroxidation in vitro.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 25, 2023
CompletedFirst Posted
Study publicly available on registry
May 9, 2023
CompletedStudy Start
First participant enrolled
May 10, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
October 30, 2023
CompletedMay 9, 2023
May 1, 2023
6 months
April 25, 2023
May 5, 2023
Conditions
Outcome Measures
Primary Outcomes (4)
Effect of wheat grass and tulsi in combination on blood pressure
Blood Pressure measured in mmHg every four week.
Every four week till 6 months
Effect of wheat grass and tulsi in combination on blood sugar
Blood Sugar measured in mmol/L every four week
Every four week till 6 months
Effect of wheat grass and tulsi in combination on weight
Weight is measure in Kg every four week.
Every four week till 6 months
Effect of wheat grass and tulsi in combination on smoking
questionnaire assesment for "Smoking habits"
Every four week till 6 months
Secondary Outcomes (8)
Effect of wheat grass and tulsi separately on blood pressure
Every four week till 6 months
Effect of wheat grass and tulsi separately on blood sugar
Every four week till 6 months
Effect of wheat grass and tulsi separately on weight
Every four week till 6 months
Effect of wheat grass and tulsi separately on smoking
Every four week till 6 months
Effect of wheat grass, tulsi and allopathic drug on blood pressure
Every four week till 6 months
- +3 more secondary outcomes
Study Arms (3)
With Wheatgrass, tulsi formulation
People using Wheatgrass and Tulsi formulation or individual
With Wheatgrass, tulsi formulation and allopathic drugs
People using Wheatgrass and Tulsi formulations or individuals with chronic disease medicine.
Same age group not using any medication
Interventions
Looking to find the role of wheatgrass and tulsi give separately or with allopathic drug
Eligibility Criteria
The population of age group 30 to 65 is targeted who have chronic disease and are taking wheat grass and tulsi formulation.
You may qualify if:
- Patients who are having a chronic disease and taking formulation wheat grass and tulsi.
- Patients who are taking wheatgrass and tulsi separately.
- Patients who are taking wheatgrass, tulsi and regular medicine. -
You may not qualify if:
- Patients below 30 years.
- Patients who are having a chronic disease but not using formulations of wheatgrass and tulsi.
- Patients who are not taking wheatgrass and tulsi separately.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Swalife Biotechlead
Study Sites (1)
Sinhgad college of Pharmacy
Pune, Maharashtra, 411041, India
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 25, 2023
First Posted
May 9, 2023
Study Start
May 10, 2023
Primary Completion
October 30, 2023
Study Completion
October 30, 2023
Last Updated
May 9, 2023
Record last verified: 2023-05